###begin article-title 0
###xml 41 46 <span type="species:ncbi:9606">Human</span>
HES-1 Is Involved in Adaptation of Adult Human beta-Cells to Proliferation In Vitro
###end article-title 0
###begin p 1
###xml 36 57 36 57 <email xmlns:xlink="http://www.w3.org/1999/xlink">sefrat@post.tau.ac.il</email>
Corresponding author: Shimon Efrat, sefrat@post.tau.ac.il
###end p 1
###begin p 2
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See  for details.
###end p 2
###begin p 3
###xml 0 10 0 10 <bold xmlns:xlink="http://www.w3.org/1999/xlink">OBJECTIVE&#8212;</bold>
###xml 54 59 <span type="species:ncbi:9606">human</span>
###xml 152 157 <span type="species:ncbi:9606">human</span>
OBJECTIVE-In vitro expansion of beta-cells from adult human islets could solve the tissue shortage for cell replacement therapy of diabetes. Culture of human islet cells typically results in <16 cell doublings and loss of insulin expression. Using cell lineage tracing, we demonstrated that the expanded cell population included cells derived from beta-cells. Understanding the molecular mechanisms involved in beta-cell fate in vitro is crucial for optimizing expansion and redifferentiation of these cells. In the developing pancreas, important cell-fate decisions are regulated by NOTCH receptors, which signal through the hairy and enhancer of split (HES)-1 transcriptional regulator. Here, we investigated the role of the NOTCH signaling pathway in beta-cell dedifferentiation and proliferation in vitro.
###end p 3
###begin p 4
###xml 0 28 0 28 <bold xmlns:xlink="http://www.w3.org/1999/xlink">RESEARCH DESIGN AND METHODS&#8212;</bold>
###xml 37 42 <span type="species:ncbi:9606">human</span>
RESEARCH DESIGN AND METHODS-Isolated human islets were dissociated into single cells. beta-Cells were genetically labeled using a Cre-lox system delivered by lentiviruses. Cells were analyzed for changes in expression of components of the NOTCH pathway during the initial weeks in culture. HES-1 expression was inhibited by a small hairpin RNA (shRNA), and the effects on beta-cell phenotype were analyzed.
###end p 4
###begin p 5
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink">RESULTS&#8212;</bold>
###xml 8 13 <span type="species:ncbi:9606">Human</span>
RESULTS-Human beta-cell dedifferentiation and entrance into the cell cycle in vitro correlated with activation of the NOTCH pathway and downregulation of the cell cycle inhibitor p57. Inhibition of HES-1 expression using shRNA resulted in significantly reduced beta-cell replication and dedifferentiation.
###end p 5
###begin p 6
###xml 0 12 0 12 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CONCLUSIONS&#8212;</bold>
CONCLUSIONS-These findings demonstrate that the NOTCH pathway is involved in determining beta-cell fate in vitro and suggest possible molecular targets for induction of beta-cell redifferentiation following in vitro expansion.
###end p 6
###begin p 7
Published ahead of print at  on 3 July 2008.
###end p 7
###begin p 8
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C Section 1734 solely to indicate this fact.
###end p 8
###begin p 9
###xml 422 423 413 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r1">1</xref>
###xml 438 439 429 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r2">2</xref>
###xml 653 654 638 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r3">3</xref>
###xml 929 930 908 909 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r4">4</xref>
###xml 931 932 910 911 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r7">7</xref>
###xml 1042 1043 1021 1022 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r8">8</xref>
###xml 1044 1046 1023 1025 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r10">10</xref>
###xml 1190 1191 1169 1170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r8">8</xref>
###xml 1192 1194 1171 1173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r10">10</xref>
###xml 1468 1470 1441 1443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r11">11</xref>
###xml 1471 1473 1444 1446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r14">14</xref>
###xml 1601 1603 1571 1573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r15">15</xref>
###xml 522 526 <span type="species:ncbi:10090">mice</span>
###xml 750 755 <span type="species:ncbi:9606">human</span>
###xml 822 827 <span type="species:ncbi:9606">human</span>
###xml 1028 1033 <span type="species:ncbi:9606">human</span>
###xml 1399 1404 <span type="species:ncbi:9606">human</span>
###xml 1450 1455 <span type="species:ncbi:10090">mouse</span>
###xml 1528 1533 <span type="species:ncbi:9606">human</span>
Replacement of beta-cells by transplantation is a promising approach for treatment of type 1 diabetes; however, its application on a large scale is limited by the availability of pancreas donors. In a normal adult pancreas, a slow rate of beta-cell renewal is responsible for maintenance of an adequate functional beta-cell mass. This rate is accelerated in conditions of increased demands for insulin, such as pregnancy (1) and obesity (2). Work in an animal model demonstrated that new beta-cells are generated in adult mice predominantly by replication of preexisting beta-cells rather than by neogenesis from insulin-negative stem/progenitor cells (3). This finding has raised hopes for recapitulation of beta-cell expansion in cultures of adult human islets. However, previous attempts at in vitro expansion of adult human beta-cells resulted in a limited number of cell population doublings and loss of insulin expression (4-7). Insulin-negative cells with a considerable proliferative capacity were derived from cultured human islets (8-10). Insulin expression in these cells could be induced by changing the culture conditions; however, its levels were low and varied among donors (8-10). One possible interpretation of these results is that beta-cells survive, dedifferentiate, and divide in culture. Recently, we applied a genetic cell lineage tracing approach for labeling cultured adult human islets and demonstrated that, in contrast to mouse beta-cells (11-14), dedifferentiated, label-positive cells derived from human beta-cells could be induced to significantly proliferate in vitro (15). These cells may be of value for development of cell therapy for type 1 diabetes, since they may retain some beta-cell-specific chromatin structure to allow their redifferentiation. Understanding the molecular mechanisms involved in beta-cell dedifferentiation and replication in vitro may facilitate the expansion and redifferentiation of these cells.
###end p 9
###begin p 10
###xml 172 174 172 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r16">16</xref>
###xml 221 223 221 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r17">17</xref>
###xml 224 226 224 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r19">19</xref>
###xml 436 438 436 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r16">16</xref>
###xml 636 638 636 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r20">20</xref>
###xml 819 823 819 823 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NGN3</italic>
###xml 883 885 883 885 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r21">21</xref>
###xml 1017 1019 1017 1019 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r22">22</xref>
###xml 1020 1022 1020 1022 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r23">23</xref>
###xml 1098 1100 1098 1100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r17">17</xref>
###xml 1268 1270 1268 1270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r17">17</xref>
###xml 1271 1273 1271 1273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r18">18</xref>
###xml 1409 1411 1409 1411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r16">16</xref>
###xml 1412 1414 1412 1414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r21">21</xref>
###xml 1637 1639 1637 1639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r24">24</xref>
###xml 1664 1666 1664 1666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r25">25</xref>
###xml 1719 1721 1719 1721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r26">26</xref>
###xml 1768 1770 1765 1767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r27">27</xref>
###xml 1282 1286 <span type="species:ncbi:10090">mice</span>
###xml 1731 1734 <span type="species:ncbi:10116">rat</span>
In the developing pancreas, important cell-fate decisions, including the switch from proliferation to differentiation, and the choice between exocrine and endocrine fates (16), as well as among different endocrine fates (17-19), are regulated by the NOTCH signaling pathway. Expression of NOTCH ligands on a differentiating cell inhibits development of the same phenotype in neighboring cells, in a mechanism termed lateral inhibition (16). Ligand binding to NOTCH receptors on a neighboring cell results in cleavage of the NOTCH intracellular domain (NICD), which enters the nucleus and forms a complex that modulates gene expression (20). The hairy and enhancer of split (HES) family of transcriptional regulators is a major target of the NICD complex. In fetal pancreata, HES-1 acts as an inhibitor of neurogenin 3 (NGN3) gene expression, which is required for islet development (21). In addition, HES-1 regulates the cell cycle by inhibiting expression of genes encoding the cyclin kinase inhibitors p27 and p57 (22,23). Some evidence suggests that it may also inhibit insulin gene expression (17). Overall, HES-1 is associated with promoting cell replication and preventing cell differentiation. Forced expression of NOTCH inhibits pancreas cell differentiation (17,18), while mice with null mutations in genes encoding NOTCH pathway components exhibit accelerated differentiation of endocrine pancreas (16,21). The NOTCH pathway is not normally expressed in the adult pancreas; however, it is activated in conditions associated with cell dedifferentiation and replication, such as regeneration following experimental pancreatitis (24), pancreatic neoplasia (25), metaplasia of cultured pancreatic exocrine cells (26), and in rat beta-cells exposed to cytokines (27).
###end p 10
###begin p 11
We hypothesized that beta-cell dedifferentiation and entrance into the cell cycle in vitro involve induction of the NOTCH pathway. Our findings demonstrate a considerable activation of the NOTCH pathway in these cells, which correlates with downregulation of the cell cycle inhibitor p57 and loss of insulin expression. Inhibition of HES-1 expression using small hairpin RNA (shRNA) results in reduced replication of cultured beta-cells and a decrease in cell dedifferentiation. These findings suggest possible molecular targets for prevention of beta-cell dedifferentiation in culture or induction of cell redifferentiation following in vitro expansion.
###end p 11
###begin title 12
RESEARCH DESIGN AND METHODS
###end title 12
###begin title 13
Islet cell culture.
###end title 13
###begin p 14
###xml 347 348 344 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r8">8</xref>
###xml 211 217 <span type="species:ncbi:9913">bovine</span>
Islets were received 2-3 days following isolation. Islets from individual donors were dissociated into single cells and cultured in CMRL-1066 medium containing 5.6 mmol/l glucose and supplemented with 10% fetal bovine serum (FBS), 100 units/ml penicillin, 100 mug/ml streptomycin, 100 mug/ml gentamicin, and 5 mug/ml amphotericine B as described (8). The cultures were refed twice a week and split 1:2 once a week.
###end p 14
###begin title 15
HES-1 inhibition and lineage tracing.
###end title 15
###begin p 16
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HES1</italic>
###xml 749 750 742 743 <sc xmlns:xlink="http://www.w3.org/1999/xlink">l</sc>
###xml 982 984 975 977 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r15">15</xref>
###xml 896 899 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1117 1120 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
HES1 shRNAs (accession nos. , , , and ) and a nontarget shRNA, cloned in pLKO.1 lentiviral vector, were obtained from the RNAi Consortium (Sigma-Aldrich). Virus was produced in 293T cells following cotransfection with the pCMVdR8.91 and pMD2.G packaging plasmids. The culture medium was harvested 48 h later. Islet cells cultured for 1-2 days were washed with PBS and infected at multiplicity of infection 2.5:1 in CMRL-1066 medium containing 8 mug/ml polybrene overnight. The medium was then replaced with regular culture medium. Four days after infection, the cells were selected for puromycin resistance (1 mug/ml) for 3 days. Two weeks after infection, the cells were harvested for further analysis. For gamma-secretase inhibition, 5 mumol/l of l-685,458 (Calbiochem) were added to cells at passage 2 (P2) for 17 h. Lineage tracing was performed using the RIP-Cre and pTrip cytomegalo virus (CMV)-loxP-DsRed2-loxP-enhanced green fluorescent protein (eGFP) viruses as described (15). Briefly, islet cells cultured for 1-2 days were infected with a 1:1:1 mixture of the three viruses (shRNA plus RIP-Cre plus pTrip CMV-loxP-DsRed2-loxP-eGFP) at a total multiplicity of infection 4:1. Selection and further analysis were carried out as described above.
###end p 16
###begin title 17
RNA analyses.
###end title 17
###begin p 18
###xml 321 328 321 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t1">Table 1</xref>
###xml 464 479 464 471 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;(&#916;&#916;ct)</sup>
###xml 516 521 <span type="species:ncbi:9606">human</span>
Total RNA was extracted using a High Pure RNA isolation kit (Roche). cDNA was synthesized using SuperScript III (Invitrogen). qPCR was performed using a Prism 7300 ABI Real-Time PCR System (Applied Biosystems). The Assay-On-Demand (Applied Biosystems) TaqMan fluorogenic probes that were used in this study are listed in Table 1. Relative quantitative analysis was performed according to the comparative computed tomography method by using the arithmetic formula 2-(DeltaDeltact). The cDNA levels were normalized to human ribosomal protein P0 cDNA.
###end p 18
###begin title 19
Immunofluorescence.
###end title 19
###begin p 20
###xml 1507 1511 1501 1505 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HES1</italic>
###xml 1557 1559 1551 1553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r28">28</xref>
###xml 1732 1734 1726 1728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r29">29</xref>
###xml 345 350 <span type="species:ncbi:10090">mouse</span>
###xml 390 396 <span type="species:ncbi:9986">rabbit</span>
###xml 427 433 <span type="species:ncbi:9986">rabbit</span>
###xml 466 471 <span type="species:ncbi:10090">mouse</span>
###xml 498 504 <span type="species:ncbi:9986">rabbit</span>
###xml 530 535 <span type="species:ncbi:10090">mouse</span>
###xml 575 581 <span type="species:ncbi:9986">rabbit</span>
###xml 616 621 <span type="species:ncbi:10090">mouse</span>
###xml 676 682 <span type="species:ncbi:9986">rabbit</span>
###xml 793 798 <span type="species:ncbi:10090">mouse</span>
###xml 807 813 <span type="species:ncbi:9986">rabbit</span>
###xml 842 847 <span type="species:ncbi:10090">mouse</span>
###xml 856 862 <span type="species:ncbi:9986">rabbit</span>
###xml 894 899 <span type="species:ncbi:10090">mouse</span>
###xml 908 914 <span type="species:ncbi:9986">rabbit</span>
###xml 1062 1067 <span type="species:ncbi:9606">human</span>
###xml 1132 1138 <span type="species:ncbi:9986">rabbit</span>
###xml 1200 1205 <span type="species:ncbi:9606">human</span>
###xml 1252 1257 <span type="species:ncbi:9606">human</span>
Cells were plated in 24-well plates on sterilized coverslips and fixed in 4% paraformaldehyde. Cells were permeabilized with 0.25% NP40 for 10 min and blocked for 10 min at room temperature in 1% BSA, 10% FBS, and 0.2% saponin. Cells were then incubated with the following primary antibodies diluted in blocking solution overnight at 4degreesC: mouse anti-insulin (1:1,000; Sigma-Aldrich), rabbit anti-p57 (1:500; Santa Cruz), rabbit anti-HES-1 (1:1,000; Chemicon), mouse anti-Ki67 (1:200; Zymed), rabbit anti-Ki67 (1:50; Zymed), mouse anti-bromo-deoxyuridine (BrdU) (1:20), rabbit anti-NICD (1:10; Cell Signaling), mouse anti-green fluorescent protein (1:500; Chemicon), and rabbit anti-GFP (1:1,000; Invitrogen). The bound antibody was visualized with a fluorescent secondary antibody (anti-mouse or anti-rabbit AMCA [1:200; Jackson], anti-mouse or anti-rabbit Cy3 [1:200; Biomeda], and anti-mouse or anti-rabbit Alexa Fluor 488 [1:200; Molecular Probes]) under a Zeiss confocal microscope. The specificity of the primary antibodies was demonstrated using FDC human colon fibroblast cells (data not shown). The specificity of the rabbit anti-HES-1 antibody from Chemicon was determined using LAN-5 human neuroblastoma cells as a negative control and human bone marrow mesenchymal stem cells as a positive control. The lack of HES-1 expression in LAN-5 cells and its presence in bone marrow mesenchymal stem cells were demonstrated using immunoblotting with a different HES-1 antibody (see below). Lack of HES1 mRNA in LAN-5 cells was previously reported (28). Nuclei were visualized by staining with DAPI (Roche) for 5 min at room temperature. BrdU staining was performed following a 24-h labeling period as previously described (29).
###end p 20
###begin title 21
Immunoblotting.
###end title 21
###begin p 22
###xml 344 350 <span type="species:ncbi:9986">rabbit</span>
###xml 394 397 <span type="species:ncbi:10116">rat</span>
###xml 429 435 <span type="species:ncbi:9986">rabbit</span>
###xml 532 536 <span type="species:ncbi:9925">goat</span>
###xml 556 561 <span type="species:ncbi:10090">mouse</span>
###xml 683 694 <span type="species:ncbi:3704">horseradish</span>
Total cellular protein was extracted in 0.5% NP40 containing a protease inhibitor cocktail (Roche). Protein concentration was determined by the bicinchoninic acid method (Pierce, Rockford, IL). A total of 70 mug protein were separated on 12% SDS-PAGE and electroblotted onto polyvinylidene fluoride membranes. The membranes were incubated with rabbit anti-HES-1 (1:1,000; a gift from T. Sudo), rat anti-NOTCH-1 (1:100; DSHB), or rabbit anti-poly (ADP-ribose) polymerase (PARP) (1:1,000; Cell Signaling). Loading was monitored using goat anti-beta-actin or mouse anti-heat shock cognate protein 70 (HSC70) (1:1,000; Santa Cruz). The bound antibody was visualized with the appropriate horseradish peroxidase-conjugated anti-IgG (Jackson) and SuperSignal West Pico Chemiluminescent Substrate (Pierce). Signal intensity was quantitated using TINA software. Cells treated with 1 mumol/l staurosporine for 6 h were used as positive control for the PARP blot.
###end p 22
###begin title 23
Apoptosis assay.
###end title 23
###begin p 24
Terminal uridine deoxynucleotidyl transferase dUTP nick-end labeling assay was performed using a Chemicon ApopTag Fluorescein In Situ Apoptosis Detection Kit according to the instructions of the manufacturer. Cells at P0 were stained 24 h following culture initiation. Cells were costained for insulin as described above.
###end p 24
###begin title 25
Insulin content and secretion.
###end title 25
###begin p 26
###xml 84 85 84 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r8">8</xref>
Glucose-stimulated insulin secretion and insulin content were assayed as described (8).
###end p 26
###begin title 27
Statistical analysis.
###end title 27
###begin p 28
###xml 44 45 44 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
Significance was determined using Student's t test. To approach a normal distribution of the qPCR data, a logarithmic transformation was performed. To account for multiple testing, the Bonferroni correction was applied.
###end p 28
###begin title 29
RESULTS
###end title 29
###begin title 30
###xml 34 39 <span type="species:ncbi:9606">human</span>
Upregulation of HES-1 in cultured human beta-cells.
###end title 30
###begin p 31
###xml 248 249 244 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r8">8</xref>
###xml 418 419 414 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r8">8</xref>
###xml 509 510 505 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 521 523 517 519 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;7</sup>
###xml 538 539 534 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 532 539 528 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>A</italic></xref>
###xml 674 678 670 674 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HES1</italic>
###xml 743 744 739 740 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 803 804 799 800 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 797 804 793 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>A</italic></xref>
###xml 867 868 863 864 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 861 868 857 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>B</italic></xref>
###xml 1195 1197 1187 1189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r30">30</xref>
###xml 1217 1218 1209 1210 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1211 1218 1203 1210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>C</italic></xref>
###xml 1452 1453 1444 1445 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1446 1453 1438 1445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>D</italic></xref>
###xml 1739 1741 1725 1727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r15">15</xref>
###xml 2476 2478 2451 2453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r15">15</xref>
###xml 2696 2697 2668 2669 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 2690 2697 2662 2669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>D</italic></xref>
###xml 2732 2733 2702 2703 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 2767 2768 2737 2738 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 1950 1953 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
Human islets were isolated from nine donors, six males and three females aged 38-60 years (mean age 50 +/- 8), with a purity ranging between 65 and 85% (mean 78 +/- 6%). Islets from each donor were dissociated and expanded in culture as described (8). Quantitative RT-PCR (qPCR) analyses of RNA extracted from these cells during the first 2 weeks of culture revealed a rapid dedifferentiation, as previously reported (8), which was manifested in a drastic decrease in insulin mRNA levels, averaging 166-fold (P = 8.7 x 10-7 at P2) (Fig. 1A) (see data on cells from individual donors in online appendix Fig. 1 [available at ]). Concomitant with this decrease, an increase in HES1 mRNA was observed in cells from all donors, averaging 4.6-fold (P = 0.006 at P2) within the first 2 weeks of culture (Fig. 1A). A similar increase was noted in HES-1 protein levels (Fig. 1B). At both RNA and protein levels, the wave of HES-1 upregulation peaked within the first 2 weeks of culture and was downregulated thereafter. To demonstrate that HES-1 upregulation in this system was dependent on NOTCH activation, we used an inhibitor of gamma-secretase, the protease complex required for generation of NICD (30). As seen in Fig. 1C, cell incubation with the inhibitor resulted in 10-fold lower HES-1 levels, supporting a NOTCH-dependent mechanism. Immunostaining could not detect significant HES-1 expression in nuclei of cells with intense insulin staining (Fig. 1D). In contrast, HES-1 was clearly detected in insulin-negative cells. To monitor HES-1 expression in dedifferentiated cells derived from beta-cells, beta-cells in freshly isolated islets were heritably labeled using a cell lineage tracing approach recently developed in our laboratory (15). The labeling approach is based on cell infection with a mixture of two lentivirus vectors: one expressing Cre recombinase under the insulin promoter (RIP-Cre) and the other a reporter cassette in which the CMV promoter is separated from an eGFP gene by a loxP-flanked stop region. Removal of the stop region in beta-cells infected by both viruses activates eGFP expression specifically in these cells, thereby allowing continuous tracking of beta-cell fate after insulin expression is lost. Residual insulin expression in beta-cells during the initial days in culture provides a sufficient window of time for RIP-Cre expression and eGFP activation. Using this method, 57.5 +/- 8.9% of insulin-positive cells were labeled with eGFP (15). Analysis of the cells expanded in culture following labeling revealed HES-1 staining in cells that lost insulin expression but maintained eGFP expression, demonstrating that they were derived from beta-cells (Fig. 1D). A total of 89.3 +/- 0.1% of eGFP+ insulin-negative cells were HES-1+ (based on counting >200 cells in cultures from each of three donors).
###end p 31
###begin title 32
###xml 69 74 <span type="species:ncbi:9606">human</span>
Changes in expression of components of the NOTCH pathway in cultured human beta-cells.
###end title 32
###begin p 33
###xml 103 109 103 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NOTCH1</italic>
###xml 199 200 199 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 222 223 222 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 216 223 216 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>A</italic></xref>
###xml 265 271 265 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NOTCH1</italic>
###xml 309 310 309 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 303 310 303 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>B</italic></xref>
###xml 360 361 360 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 354 361 354 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>B</italic></xref>
###xml 364 370 364 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NOTCH2</italic>
###xml 375 381 375 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NOTCH3</italic>
###xml 437 438 437 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 449 451 449 451 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;5</sup>
###xml 474 475 474 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 486 488 486 488 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;4</sup>
###xml 575 583 575 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NOTCH1&#8211;3</italic>
###xml 623 629 623 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NOTCH4</italic>
###xml 681 682 681 682 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 693 695 693 695 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;5</sup>
###xml 745 749 745 749 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HES1</italic>
###xml 764 772 764 772 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NOTCH1&#8211;3</italic>
###xml 1239 1240 1231 1232 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1233 1240 1225 1232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>A</italic></xref>
###xml 1243 1249 1235 1241 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DELTA1</italic>
###xml 1302 1303 1294 1295 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1314 1316 1306 1308 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;4</sup>
###xml 1361 1365 1353 1357 <italic xmlns:xlink="http://www.w3.org/1999/xlink">JAG1</italic>
###xml 1427 1431 1419 1423 <italic xmlns:xlink="http://www.w3.org/1999/xlink">JAG2</italic>
###xml 1484 1485 1476 1477 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1496 1498 1488 1490 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;5</sup>
###xml 1677 1678 1669 1670 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1671 1678 1663 1670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>C</italic></xref>
###xml 1958 1959 1947 1948 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1952 1959 1941 1948 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>C</italic></xref>
qPCR analyses revealed changes in levels of transcripts encoding the four members of the NOTCH family. NOTCH1 transcripts were upregulated on average by 3.6-fold within the first 2 weeks of culture (P = 0.02 at P2) (Fig. 2A). A similar increase was detected in the NOTCH1 120-kd transmembrane fragment (Fig. 2B), paralleling the changes in HES-1 levels (Fig. 1B). NOTCH2 and NOTCH3 were significantly upregulated on average by 9.7-fold (P = 8.8 x 10-5 at P2) and 10.1-fold (P = 1.0 x 10-4 at P2), respectively, within the first 2 weeks of culture. Overall, the activation of NOTCH1-3 paralleled that of HES-1. In contrast, NOTCH4 was drastically downregulated, on average 50-fold (P = 3.0 x 10-5 at P2) from its level in primary islets. As with HES1 upregulation, NOTCH1-3 upregulation peaked within the first 2 weeks of culture and was downregulated thereafter. Transcripts encoding presenilin-1, a component of the gamma-secretase complex, and recombination signal-binding protein 1 for J-kappa (RBPJK), a protein that participates in the NICD nuclear complex, were not significantly changed in the cultured cells (data not shown). In contrast, transcripts for NOTCH ligands were downregulated during the initial weeks of culture (Fig. 2A). DELTA1 transcripts were downregulated on average 3.3-fold (P = 1.4 x 10-4 at P2) within the first 2 weeks of culture. JAG1 transcripts were not significantly changed (data not shown). JAG2 transcripts were downregulated on average 5.5-fold (P = 1.9 x 10-5 at P2) within the first 2 weeks of culture. The increased activity of the NOTCH pathway was manifested by appearance of NICD in cell nuclei, as revealed by immunostaining (Fig. 2C). Similar to the pattern of HES-1 immunostaining, staining for NICD could not be detected in cells intensely stained for insulin. NICD staining was detected in all (100%) lineage-labeled, insulin-negative cells identified as originating from beta-cells by eGFP expression (Fig. 2C) (based on counting >200 cells in cultures from each of three donors).
###end p 33
###begin title 34
Changes in expression of cell cycle inhibitors.
###end title 34
###begin p 35
###xml 224 226 224 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r22">22</xref>
###xml 227 229 227 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r23">23</xref>
###xml 332 334 329 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r22">22</xref>
###xml 379 380 376 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 439 440 436 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 433 440 430 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>A</italic></xref>
###xml 521 522 518 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 664 665 661 662 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 723 724 720 721 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 807 808 804 805 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 801 808 798 805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>B</italic></xref>
###xml 1115 1116 1112 1113 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1130 1131 1127 1128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1124 1131 1121 1128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>C</italic></xref>
###xml 1259 1260 1256 1257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r8">8</xref>
###xml 1372 1374 1366 1368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r31">31</xref>
###xml 314 319 <span type="species:ncbi:9606">human</span>
To evaluate the consequences of increased HES-1 expression in the cultured islet cells, we analyzed changes in transcripts of genes encoding cyclin kinase inhibitors, which are among the main targets of repression by HES-1 (22,23). Transcripts encoding p57, which is thought to be the main cell cycle inhibitor in human beta-cells (22), were downregulated, on average, 2.9-fold (P = 0.004 at P2) within the first 2 weeks of culture (Fig. 3A). A further reduction was observed at P3, averaging 7.1-fold, compared with P0 (P = 0.002). This finding was supported by immunostaining for p57, which showed its presence in all (100%) lineage-labeled insulin-positive eGFP+ cells and its absence in all (100%) insulin-negative eGFP+ cells (based on counting >200 cells in cultures from each of three donors) (Fig. 3B). In contrast to p57, transcripts for p21 were upregulated in cells from all donors, and those for p27 varied considerably among donors (data not shown). The downregulation of p57 transcripts and protein correlated with cell entrance into the cell cycle, as manifested by Ki67 staining in p57-negative eGFP+ cells (Fig. 3C). The nuclear area of replicating cells was 2.5- to 4-fold larger than that of insulin-positive cells, as previously reported (8). The increase in cell size is likely associated with recruitment of quiescent beta-cells into the cell cycle (31).
###end p 35
###begin title 36
Inhibition of HES-1 expression prevents induction of beta-cell replication.
###end title 36
###begin p 37
###xml 192 196 189 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HES1</italic>
###xml 484 488 481 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HES1</italic>
###xml 731 732 728 729 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 725 732 722 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4<italic>A</italic></xref>
###xml 758 762 755 759 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HES1</italic>
###xml 1066 1067 1063 1064 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1060 1067 1057 1064 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4<italic>B</italic></xref>
###xml 1108 1109 1105 1106 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1197 1198 1191 1192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1191 1198 1185 1192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4<italic>B</italic></xref>
###xml 1252 1256 1246 1250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HES1</italic>
###xml 1384 1385 1378 1379 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1378 1385 1372 1379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4<italic>C</italic></xref>
###xml 1740 1744 1734 1738 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HES1</italic>
###xml 1930 1934 1924 1928 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HES1</italic>
###xml 1975 1976 1969 1970 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 2087 2088 2081 2082 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 2081 2088 2075 2082 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4<italic>D</italic></xref>
###xml 2204 2208 2198 2202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HES1</italic>
###xml 2237 2238 2231 2232 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 2333 2338 2327 2332 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NOTCH</italic>
###xml 2441 2442 2435 2436 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 2435 2442 2429 2436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4<italic>D</italic></xref>
###xml 398 403 <span type="species:ncbi:9606">human</span>
To further correlate the induction of beta-cell replication with HES-1 upregulation, HES-1 induction during the initial weeks of culture was inhibited using shRNA. Following screening of four HES1 shRNA sequences for activity in 293T cells, one of four (TRCN18993) was selected as most efficient, based on reduction in HES-1 protein levels, as analyzed by immunoblotting (data not shown). Isolated human islets were dissociated, and the cells were infected with a lentivirus encoding HES1 shRNA before culture under standard conditions. Selection for drug resistance allowed elimination of uninfected cells. Cells infected with a nontarget shRNA lentivirus and selected under similar conditions served as control. As seen in Fig. 4A, cell infection with the HES1 shRNA virus resulted in up to six-times-lower HES-1 protein levels, compared with cells infected with the control virus. The lower HES-1 levels were associated with a diminished cell proliferation compared with cells infected with the control vector, as judged by staining for BrdU incorporation (Fig. 4B). In addition, staining for Ki67 in eGFP+ cells demonstrated a lower replication rate among cells derived from beta-cells (Fig. 4B). The reduced replication in cells infected with the HES1 shRNA virus did not correlate with an increase in cell apoptosis, as judged by immunoblotting analysis for cleaved PARP (Fig. 4C). In addition, terminal uridine deoxynucleotidyl transferase dUTP nick-end labeling assay did not detect significant changes between cells at P2 treated with either virus and cells at P0 among insulin-expressing cells or the total cell population (averaging 1.41, 2.19, and 1.64% apoptotic cells among insulin-positive cells at P0, P2 cells treated with HES1 shRNA, and P2 cells treated with nontarget virus, respectively, based on counting 500 cells in cultures from each of three donors). The reduced proliferation of cells infected with the HES1 shRNA virus correlated with a 5.7-fold (P = 0.001) higher level of p57 transcripts, compared with those in cells infected with the control virus (Fig. 4D) (see data on cells from individual donors in online appendix Fig. 2). The levels of p57 transcripts obtained with HES1 shRNA were 3.3-fold higher (P = 0.04) compared with P0. The reduced HES-1 levels did not significantly affect the levels of NOTCH transcripts, which is consistent with the position of HES-1 downstream of NOTCH in the pathway (Fig. 4D).
###end p 37
###begin title 38
Inhibition of HES-1 expression reduces beta-cell dedifferentiation.
###end title 38
###begin p 39
###xml 43 47 43 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HES1</italic>
###xml 255 256 252 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 267 269 264 266 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;4</sup>
###xml 330 331 327 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 324 331 321 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f5" ref-type="fig">Fig. 5<italic>A</italic></xref>
###xml 403 407 397 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDX1</italic>
###xml 412 419 406 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NEUROD1</italic>
###xml 435 436 429 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 460 461 454 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 513 517 507 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HES1</italic>
###xml 531 532 525 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 525 532 519 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f5" ref-type="fig">Fig. 5<italic>A</italic></xref>
###xml 549 553 543 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDX1</italic>
###xml 558 565 552 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NEUROD1</italic>
###xml 598 602 592 596 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HES1</italic>
###xml 737 741 731 735 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HES1</italic>
###xml 901 902 895 896 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 975 979 969 973 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HES1</italic>
###xml 1044 1045 1038 1039 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1038 1045 1032 1039 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f5" ref-type="fig">Fig. 5<italic>B</italic></xref>
###xml 1097 1098 1091 1092 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1150 1154 1144 1148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HES1</italic>
###xml 1230 1231 1221 1222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1236 1237 1227 1228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1224 1237 1215 1228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f5" ref-type="fig">Fig. 5<italic>B</italic> and <italic>C</italic></xref>
###xml 1276 1280 1267 1271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HES1</italic>
###xml 1308 1309 1299 1300 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1376 1377 1367 1368 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1370 1377 1361 1368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f6" ref-type="fig">Fig. 6<italic>A</italic></xref>
###xml 1608 1609 1599 1600 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1602 1609 1593 1600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f6" ref-type="fig">Fig. 6<italic>B</italic></xref>
###xml 1661 1665 1652 1656 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HES1</italic>
###xml 1693 1694 1684 1685 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1796 1797 1787 1788 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1790 1797 1781 1788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f6" ref-type="fig">Fig. 6<italic>B</italic></xref>
###xml 1831 1835 1822 1826 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HES1</italic>
The lower HES-1 levels in cells expressing HES1 shRNA resulted in a reduced rate of cell dedifferentiation, as manifested by higher levels of transcripts encoding differentiated beta-cell markers. Thus, levels of insulin transcripts were 6.6-fold higher (P = 5.5 x 10-4) compared with cells infected with the control virus (Fig. 5A). Similarly, transcript levels for the beta-cell transcription factors PDX1 and NEUROD1 were 4.4-fold (P = 0.005) and 3.3-fold (P = 0.004) higher, respectively, in cells expressing HES1 shRNA (Fig. 5A). The levels of PDX1 and NEUROD1 transcripts in cells expressing HES1 shRNA were 0.52 and 0.54 of those in primary islets, respectively. In contrast, the levels of insulin transcripts in cells expressing HES1 shRNA were ninefold lower compared with those in primary islets. In agreement with the higher insulin mRNA levels, insulin immunostaining detected a fourfold (P = 0.016) higher number of insulin-positive cells in cultures expressing HES1 shRNA compared with those treated with the control virus (Fig. 5B). The fraction of insulin-positive cells among eGFP+ cells was also threefold higher in the presence of HES1 shRNA, indicating that fewer beta-cells underwent dedifferentiation (Fig. 5B and C). Insulin content in cells expressing HES1 shRNA was 3.5-fold higher (P = 0.03) compared with cells treated with the control virus (Fig. 6A), although these levels were 14-fold lower compared with intact islets before trypsinization. Cells at P2 maintained the same two- to threefold increase in insulin secretion in response to glucose observed in intact islets (Fig. 6B). However, insulin secretion from cells expressing HES1 shRNA was 6.8-fold higher (P = 0.006) compared with cells treated with the control virus, in response to 16 mmol/l glucose (Fig. 6B). Nevertheless, cells expressing HES1 shRNA secreted a much higher fraction of their insulin content (15.5%), compared with intact islets (3.9%), during a 30-min assay. (Cells infected with the nontarget virus secreted 19.7% of their content.)
###end p 39
###begin p 40
###xml 130 134 130 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HES1</italic>
###xml 185 186 185 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 179 186 179 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f7" ref-type="fig">Fig. 7<italic>A</italic></xref>
###xml 343 344 343 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 355 357 355 357 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;5</sup>
###xml 373 374 373 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 385 387 385 387 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;4</sup>
###xml 450 454 450 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HES1</italic>
###xml 595 596 595 596 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 607 609 607 609 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;5</sup>
###xml 625 626 625 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 637 639 637 639 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;4</sup>
###xml 677 681 677 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDX1</italic>
###xml 709 710 709 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 721 723 721 723 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;5</sup>
###xml 739 740 739 740 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 751 753 751 753 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;4</sup>
###xml 795 802 795 802 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NEUROD1</italic>
###xml 830 831 830 831 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 842 844 842 844 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;5</sup>
###xml 860 861 860 861 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 870 872 870 872 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;6</sup>
###xml 951 955 951 955 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HES1</italic>
To verify that these results were due to specific inhibition of HES-1 expression, the studies were reproduced with two additional HES1 shRNAs, TRCN18990 and TRCN18991. As seen in Fig. 7A, cell infection with viruses encoding these shRNAs resulted in reduction in cellular HES-1 protein levels. The reduction in HES-1 correlated with 5.3-fold (P = 3.3 x 10-5) and 2.2-fold (P = 6.6 x 10-4) higher levels of p57 transcripts in cells expressing the two HES1 shRNAs, respectively, compared with the levels in cells infected with the nontarget virus. The levels of insulin transcripts were 3.4-fold (P = 1.3 x 10-5) and 1.9-fold (P = 2.8 x 10-4) higher, respectively. The levels of PDX1 transcripts were 4.0-fold (P = 9.2 x 10-5) and 2.5-fold (P = 1.9 x 10-4) higher, respectively, and the levels of NEUROD1 transcripts were 7.7-fold (P = 3.5 x 10-5) and 3.1-fold (P = 8 x 10-6) higher, respectively. These results are comparable with those obtained using HES1 shRNA TRCN18993, indicating that the effects on cell proliferation and differentiation were caused by specific inhibition of HES-1 expression.
###end p 40
###begin title 41
DISCUSSION
###end title 41
###begin p 42
###xml 240 248 237 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NOTCH1&#8211;3</italic>
###xml 253 257 250 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HES1</italic>
###xml 304 310 301 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NOTCH4</italic>
###xml 334 340 331 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DELTA1</italic>
###xml 345 349 342 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink">JAG2</italic>
###xml 1067 1068 1061 1062 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 59 64 <span type="species:ncbi:9606">human</span>
Our findings demonstrate that culture of dissociated adult human islet cells in serum-containing medium, which induces beta-cell dedifferentiation and replication, involves activation of elements of the NOTCH pathway. Transcript levels for NOTCH1-3 and HES1 are upregulated. In contrast, transcripts for NOTCH4, and the NOTCH ligands DELTA1 and JAG2, are downregulated. These changes were initially observed in a mixed population of islet cells, which likely included contaminating duct and exocrine cells. Using virus-mediated cell lineage tracing, we then determined that these changes occurred in beta-cells. The upregulation of the NOTCH pathway correlated with cell dedifferentiation, as manifested by a dramatic decrease in insulin transcripts, and by cell entrance into the cell cycle, as manifested by downregulation of p57 transcripts and an increase in Ki67 staining. The findings at the RNA level were supported by immunostaining, which demonstrated a negative correlation between the presence of HES-1 or NICD in the nucleus and insulin expression in eGFP+ cells, which marked their origin from beta-cells. These in situ analyses also detected a positive correlation between p57 and insulin expression, confirming the view that beta-cell replication involves dedifferentiation.
###end p 42
###begin p 43
The key role of HES-1 in these events was revealed by inhibiting its upregulation with shRNA. In these cells, the decrease in p57 was prevented and cell proliferation was greatly reduced. While cell dedifferentiation was not completely prevented, it was significantly inhibited compared with cells in which HES-1 upregulation was not repressed. This was manifested by higher levels of insulin transcripts and fraction of cells immunostaining for insulin, as well as transcripts encoding beta-cell transcription factors. In addition, loss of insulin content and secretion was less pronounced. These findings suggest that a partial cell dedifferentiation is independent of HES-1 activity and cell replication; however, induction of advanced dedifferentiation and cell replication requires HES-1 upregulation. This interpretation is supported by the finding that the bulk of decrease in insulin mRNA occurs during the first week, thus preceding the peak in HES-1 mRNA levels. It is therefore possible that loss of most of the insulin content is a precondition for beta-cell entrance into cell cycle in vitro.
###end p 43
###begin p 44
###xml 225 227 225 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r16">16</xref>
###xml 381 383 381 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r32">32</xref>
###xml 712 714 712 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r16">16</xref>
Given the fact that upregulation of the NOTCH pathway in islet cell cultures followed cell dissociation into single cells, it is unlikely that it was trigerred by a cell-associated ligand, as in the lateral inhibition model (16). Rather, it is possible that this pathway is activated in response to soluble serum components, as was demonstrated in a number of cultured cell types (32). This possibility is supported by our findings of decreased expression of NOTCH ligands in islet cell cultures concomitant with HES-1 upregulation. This is reminiscent of the low levels of NOTCH ligands in the embryonic pancreas cells expressing HES-1, which are directed for further proliferation rather than differentiation (16).
###end p 44
###begin p 45
###xml 30 35 30 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NOTCH</italic>
###xml 63 69 63 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NOTCH1</italic>
###xml 71 77 71 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NOTCH2</italic>
###xml 83 89 83 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NOTCH3</italic>
###xml 126 132 126 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NOTCH4</italic>
###xml 193 199 193 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NOTCH1</italic>
###xml 204 210 204 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NOTCH2</italic>
###xml 248 254 248 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NOTCH3</italic>
###xml 259 265 259 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NOTCH4</italic>
###xml 330 332 330 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r21">21</xref>
###xml 353 359 353 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NOTCH4</italic>
###xml 399 400 399 400 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
Among the four members of the NOTCH family that were analyzed, NOTCH1, NOTCH2, and NOTCH3 transcripts were upregulated, while NOTCH4 transcripts were greatly downregulated. While expression of NOTCH1 and NOTCH2 was implicated in islet development, NOTCH3 and NOTCH4 expression was documented in mesenchymal and endothelial cells (21). Downregulation of NOTCH4 may reflect the elimination of a NOTCH4+ subpopulation, which is present in the original islet cell suspension but for some reason is not maintained in continuous culture.
###end p 45
###begin p 46
###xml 287 288 284 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r8">8</xref>
###xml 289 291 286 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r15">15</xref>
The wave of HES-1 upregulation peaked within the first 2 weeks of culture and was downregulated thereafter. Nevertheless, the effects of HES-1 were not reversed, as manifested by continuous replication of cells derived from dedifferentiated beta-cells for up to 16 population doublings (8,15). The levels of p57 and insulin transcripts did not rebound thereafter, suggesting that their reinduction requires other signals in addition to the decrease in the inhibitory effect of HES-1. This finding suggests a transient role of HES-1 upregulation that is limited to the initial adaptation of islet cells to culture, after which cell replication may continue in the presence of the lower HES-1 levels found in nonreplicating cells.
###end p 46
###begin p 47
In summary, our findings provide evidence for activation of the NOTCH pathway in adult cells and offer an in vitro model system for studying interactions within this pathway. In addition, the findings emphasize the role of components of the NOTCH pathway in the transition of quiescent beta-cells into a dedifferentiated, proliferative state in vitro. Our findings demonstrate a negative correlation between replication and maintenance of differentiated function in cultured beta-cells, suggesting that significant cell expansion inevitably involves dedifferentiation and will require the development of methods for cell redifferentiation following expansion. Components of the NOTCH pathway may represent molecular targets for induction of redifferentiation of the expanded cells.
###end p 47
###begin title 48
Supplementary Material
###end title 48
###begin title 49
Online-Only Appendix
###end title 49
###begin p 50
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human islets were provided by the Cell Isolation and Transplantation Center at the University of Geneva School of Medicine and San Raffaele Hospital, Milan, Italy, through the European Consortium for Islet Transplantation "Islets for Research" distribution program, sponsored by the Juvenile Diabetes Research Foundation award 6-2005-1178, and by the Diabetes Cell Therapy unit, Faculty of Medicine, Lille 2 University. This work was supported by grants from the Israel Science Foundation and Juvenile Diabetes Research Foundation (to S.E.).
###end p 50
###begin p 51
We thank T. Sudo for anti-HES1 antibody and Ran Elkon for assistance with statistical analyses.
###end p 51
###begin p 52
This work was performed in partial fulfillment of the requirements for a PhD degree of Yael Bar.
###end p 52
###begin title 53
REFERENCES
###end title 53
###begin p 54
###xml 60 61 60 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 135 136 132 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 391 392 386 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 462 463 457 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 474 476 469 471 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;5</sup>
###xml 493 494 488 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 507 511 502 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HES1</italic>
###xml 530 534 525 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HES1</italic>
###xml 581 582 576 577 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 592 593 587 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 731 732 723 724 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 867 868 855 856 <sc xmlns:xlink="http://www.w3.org/1999/xlink">l</sc>
###xml 912 913 900 901 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 959 969 947 957 <italic xmlns:xlink="http://www.w3.org/1999/xlink">left panel</italic>
###xml 979 980 967 968 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1012 1023 997 1008 <italic xmlns:xlink="http://www.w3.org/1999/xlink">right panel</italic>
###xml 1059 1069 1044 1054 <italic xmlns:xlink="http://www.w3.org/1999/xlink">left panel</italic>
###xml 34 39 <span type="species:ncbi:9606">human</span>
Upregulation of HES-1 in cultured human islet cells and eGFP+ cells derived from beta-cells correlates with downregulation of insulin. A: qPCR analysis of RNA extracted from islet cells derived from nine donors. P indicates passage number and weeks in culture. RQ indicates relative quantification compared with P0, which represents islet cells at culture initiation. Data are means +/- SD (n = 9). Asterisks indicate statistical significance, compared with P0 (P < 3.3 x 10-5 for insulin and P < 0.006 for HES1). The increase in HES1 mRNA levels at P1 was marginally significant (P = 0.06). B: Immunoblotting for HES-1 in protein extracted from islet cells at the indicated passage number. beta-Actin served as a loading control. C: Immunoblotting for HES-1 in protein extracted from islet cells at P2, following a 17-h incubation with the gamma-secretase inhibitor l-685458. HSC70 served as a loading control. D: Immunofluorescence analysis of islet cells (left panel) and eGFP+ cells derived from beta-cells (right panel) following 10 days in culture. The left panel is merged with a phase contrast image. Arrow points to a beta-cell that still expresses insulin and is not labeled for HES-1. eGFP is detected in both cytoplasm and nucleus. Bar = 20 mum. (Please see  for a high-quality digital representation of this figure.)
###end p 54
###begin p 55
###xml 72 73 72 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 105 106 102 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 343 344 338 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 414 415 409 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 427 433 422 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NOTCH1</italic>
###xml 435 436 430 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 448 454 443 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NOTCH2</italic>
###xml 456 457 451 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 466 468 461 463 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;4</sup>
###xml 473 479 468 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NOTCH3</italic>
###xml 481 482 476 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 494 500 489 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NOTCH4</italic>
###xml 502 503 497 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 516 520 511 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DLL1</italic>
###xml 522 523 517 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 536 540 531 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink">JAG2</italic>
###xml 559 565 554 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NOTCH3</italic>
###xml 612 613 607 608 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 623 624 618 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 788 789 783 784 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 835 845 830 840 <italic xmlns:xlink="http://www.w3.org/1999/xlink">left panel</italic>
###xml 855 856 850 851 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 888 899 880 891 <italic xmlns:xlink="http://www.w3.org/1999/xlink">right panel</italic>
###xml 46 51 <span type="species:ncbi:9606">human</span>
Upregulation of the NOTCH pathway in cultured human islet cells and eGFP+ cells derived from beta-cells. A: qPCR analysis of RNA extracted from islet cells derived from eight donors at the indicated passage numbers. P indicates passage number and weeks in culture. RQ indicates relative quantification compared with P0. Data are means +/- SD (n = 8). Asterisks indicate statistical significance, compared with P0 (P < 0.03 for NOTCH1; P < 0.04 for NOTCH2; P < 9 x 10-4 for NOTCH3; P < 0.03 for NOTCH4; P < 0.005 for DLL1; P < 0.026 for JAG2). The increase in NOTCH3 mRNA levels at P3 was marginally significant (P = 0.06). B: Immunoblotting for NOTCH1 120-kd transmembrane fragment in protein extracted from islet cells at the indicated passage number. HSC70 served as a loading control. C: Immunofluorescence analysis of islet cells (left panel) and eGFP+ cells derived from beta-cells (right panel) following 10 days in culture. Bar = 20 mum. (Please see  for a high-quality digital representation of this figure.)
###end p 55
###begin p 56
###xml 60 61 60 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 93 94 90 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 331 332 326 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 398 399 393 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 409 410 404 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 415 416 410 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 453 454 448 449 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 530 531 522 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 549 550 541 542 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 633 634 625 626 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 702 703 691 692 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 721 722 710 711 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 34 39 <span type="species:ncbi:9606">human</span>
Downregulation of p57 in cultured human islet cells and eGFP+ cells derived from beta-cells. A: qPCR analysis of RNA extracted from islet cells derived from eight donors at the indicated passage numbers. P indicates passage number and weeks in culture. RQ indicates relative quantification compared with P0. Data are means +/- SD (n = 8). Stars indicate statistical significance, compared with P0 (P < 0.03). B and C: Immunofluorescence analysis of eGFP+ cells derived from beta-cells following 10 days in culture. Solid arrow in B points to an eGFP+ cell that has lost both insulin and p57 expression; dashed arrow points to an eGFP+ beta-cell that maintains both insulin and p57 expression. Arrow in C points to an eGFP+ cell that maintains p57 expression and is not labeled for Ki67. Bar = 20 mum. (Please see  for a high-quality digital representation of this figure.)
###end p 56
###begin p 57
###xml 100 101 100 101 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 133 134 130 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 224 228 221 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HES1</italic>
###xml 305 317 299 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B: Top panel</italic>
###xml 336 337 330 331 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 396 400 390 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HES1</italic>
###xml 460 461 452 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 523 524 515 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 534 546 526 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bottom panel</italic>
###xml 565 566 557 558 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 583 584 575 576 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 647 651 639 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HES1</italic>
###xml 792 793 753 754 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 893 899 854 860 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 3</italic>
###xml 904 908 865 869 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HES1</italic>
###xml 932 938 893 899 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 4</italic>
###xml 974 980 935 941 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 1</italic>
###xml 994 1000 955 961 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 2</italic>
###xml 1073 1079 1034 1040 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 1</italic>
###xml 1145 1146 1103 1104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1221 1225 1179 1183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HES1</italic>
###xml 1340 1341 1296 1297 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1394 1395 1350 1351 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1516 1516 1441 1441 <inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="permzspch004.jpg"/>
###xml 1518 1522 1443 1447 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HES1</italic>
###xml 74 79 <span type="species:ncbi:9606">human</span>
Prevention of HES-1 upregulation by shRNA reduces replication of cultured human islet cells and eGFP+ cells derived from beta-cells. A: Immunoblotting for HES-1 in protein extracted from islet cells following infection with HES1 shRNA TRCN18993 or nontarget virus. beta-Actin served as a loading control. B: Top panel: Incidence of BrdU+ cells among cultured islet cells following infection with HES1 shRNA TRCN18993 or nontarget virus. Data are means +/- SD (n = 3 donors; >1,000 cells counted in culture from each donor; P = 0.02). Bottom panel: Incidence of Ki67+ cells among eGFP+ cells from two representative donors following infection with HES1 shRNA or nontarget virus. Data are based on >1,000 cells counted in culture from each donor. square, G13; blacksquare, square, filled, I10. C: Immunoblotting for PARP in protein extracted from islet cells following infection with nontarget (lane 3) or HES1 shRNA TRCN18993 virus (lane 4). Uninfected cells incubated with (lane 1) or without (lane 2) the apoptotic agent staurosporin served as controls. The lower band in lane 1 represents cleaved PARP. beta-Actin served as a loading control. D: qPCR analysis of RNA extracted from islet cells following infection with HES1 shRNA TRCN18993 or nontarget virus. RQ indicates relative quantification compared with P0. Data are means +/- SD (n = 3 donors). Only the change in p57 is significant (P = 0.001 vs. cells infected with nontarget virus, indicated by star). blacksquare, square, filled, P0; square, nontarget;, HES1 shRNA. All the analyses were done 14 days following viral infection.
###end p 57
###begin p 58
###xml 79 80 76 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 155 159 152 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HES1</italic>
###xml 274 275 269 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 343 347 338 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HES1</italic>
###xml 424 425 419 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 487 487 451 451 <inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="permzspch004.jpg"/>
###xml 489 493 453 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HES1</italic>
###xml 501 502 465 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 504 508 468 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Left</italic>
###xml 598 602 562 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HES1</italic>
###xml 662 663 624 625 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 725 726 687 688 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 737 742 699 704 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Right</italic>
###xml 790 791 752 753 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 859 863 818 822 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HES1</italic>
###xml 1076 1077 1004 1005 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1125 1126 1053 1054 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1158 1162 1086 1090 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HES1</italic>
Prevention of HES-1 upregulation by shRNA reduces beta-cell dedifferentiation. A: qPCR analysis of RNA extracted from islet cells following infection with HES1 shRNA TRCN18993 or nontarget virus. RQ indicates relative quantification compared with P0. Data are means +/- SD (n = 3 donors). The changes in all three genes in cells infected with HES1 shRNA, compared with cells infected with nontarget virus, were significant (P < 0.004). blacksquare, square, filled, P0; square, nontarget;, HES1 shRNA. B: Left: Incidence of insulin-positive cells among cultured islet cells following infection with HES1 shRNA TRCN18993 or nontarget virus. Data are means +/- SD (n = 3 donors; >1,000 cells counted in culture from each donor; P = 0.016). Right: Incidence of insulin-positive cells among eGFP+ beta-cells from two representative donors following infection with HES1 shRNA or nontarget virus. Data are based on >1,000 cells counted in culture from each donor. Significant differences compared with nontarget are indicated by stars. square, G13; blacksquare, square, filled, I10. C: Immunofluorescence analysis of insulin in eGFP+ cells following infection with HES1 shRNA TRCN18993 or nontarget virus. Bar = 100 mum. All the analyses were done 14 days following viral infection. (Please see  for a high-quality digital representation of this figure.)
###end p 58
###begin p 59
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HES1</italic>
###xml 151 152 151 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 193 197 193 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HES1</italic>
###xml 286 287 284 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 346 347 344 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 357 358 355 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 447 448 443 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 618 619 614 615 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
HES1 shRNA reduces the decrease in insulin content and glucose-stimulated insulin secretion observed during dedifferentiation of cultured islet cells. A: Insulin content in cells infected with HES1 shRNA TRCN18993 or nontarget virus compared with primary islets. Data are means +/- SD (n = 3 donors). Asterisks indicate statistical significance (P = 0.03). B: Insulin secretion in response to glucose during a 30-min assay. Data are means +/- SD (n = 3 individual experiments from a representative donor). Asterisk indicate statistical significance of the difference between 0 and 16 mmol/l glucose in each cell type (P < 0.04). blacksquare, square, filled, 0 mmol/l; square, 16 mmol/l.
###end p 59
###begin p 60
###xml 11 15 11 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HES1</italic>
###xml 91 92 91 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 190 194 190 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HES1</italic>
###xml 278 279 278 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 362 366 362 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HES1</italic>
###xml 505 506 503 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 648 648 615 615 <inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="permzspch004.jpg"/>
Effects of HES1 shRNAs TRCN18990 and TRCN18991 on gene expression in cultured islet cells. A: Immunoblotting for HES-1 in protein extracted from islet cells 14 days following infection with HES1 shRNA TRCN18990, TRCN18991, or nontarget virus. HSC70 served as a loading control. B: qPCR analysis of RNA extracted from islet cells 14 days following infection with HES1 shRNAs or nontarget virus. RQ indicates relative quantification compared with cells infected with nontarget virus. Data are means +/- SD (n = 3). Significant differences compared with nontarget are indicated by asterisks. blacksquare, square, filled, nontarget; square, TRCN18990; , TRCN18991.
###end p 60
###begin p 61
Assay-on-Demand (Applied Biosystems) TaqMan fluorogenic probes used in the study
###end p 61

